Evidence map›Paper›PMID 32767762›Full record

ArticlePhotochemistry and photobiology2021

The Endogenous Tryptophan-derived Photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) is a Nanomolar Photosensitizer that Can be Harnessed for the Photodynamic Elimination of Skin Cancer Cells in Vitro and in Vivo.

Rebecca Justiniano, Lohanna de Faria Lopes, Jessica Perer, Anh Hua, Sophia L Park, Jana Jandova, Maurício S Baptista, Georg T Wondrak

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. To activate NAD(P)H oxidase with a brief pulse of photodynamic action.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. HSPA6 and its role in cancers and other diseases.Molecular biology reports · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Rebecca JustinianoDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
Lohanna de Faria LopesBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
Jessica PererDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
Anh HuaDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
Sophia L ParkDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
Jana JandovaDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
Maurício S BaptistaBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-7079-7666
Georg T WondrakDepartment of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.ORCID 0000-0003-4799-8608
University of Arizona · USUniversidade de São Paulo · BR

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Targeted Prevention for Non-Melanoma Skin CancerP01CA229112 · NCI · UNIVERSITY OF ARIZONA · PI MANSOUR, HEIDI M. · 2019 to 2023
$7.1M
Repurposing Clinical ACT Antimalarials for Experimental Melanoma InterventionR01CA229418 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2019 to 2023
$1.7M
Exploring the role of HOCI in skin photodamage, immunosuppression, and carcinogenesisR21ES029579 · NIEHS · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2019 to 2020
$409k
Zinc dysregulation as a druggable target in human skin photocarcinogenesisR03CA230949 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2018 to 2019
$147k
NCI NIH HHS P01 CA229112NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA229418NCI NIH HHS R03 CA230949NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R21 ES029579NIEHS NIH HHS T32 ES007091NIH HHS CA023074NIH HHS ES006694NIH HHS ES007091NIH HHS P01CA229112NIH HHS R01CA229418NIH HHS R03CA230949NIH HHS R21ES029579
6 · The paper itself

Abstract

UV-chromophores contained in human skin may act as endogenous sensitizers of photooxidative stress and can be employed therapeutically for the photodynamic elimination of malignant cells. Here, we report that 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan-derived photoproduct and endogenous aryl hydrocarbon receptor agonist, displays activity as a nanomolar sensitizer of photooxidative stress, causing the photodynamic elimination of human melanoma and nonmelanoma skin cancer cells in vitro and in vivo. FICZ is an efficient UVA/Visible photosensitizer having absorbance maximum at 390 nm (ε = 9180 L mol

Indexed as

PhotochemotherapyAnimalsCarbazolesCarcinoma, Squamous CellCell DeathCell Line, TumorEpidermisHumansKeratinocytesMelanomaMiceMitochondriaOxidative StressPhotosensitizing AgentsSkin NeoplasmsTryptophan6-formylindolo(3,2-b)carbazoleCarbazolesPhotosensitizing AgentsTryptophan

Identifiers

PMID32767762
PMCPMC8265325
OpenAlexW3047696555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.